Breast Lobular Carcinoma — Trials

Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05931302	Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT(GALILEE)	active not recruiting	N/A	40	Centre Hospitalier Intercommunal de Toulon La Seyne sur MerOTHER	1	Jul 7, 2026	clinicaltrials
NCT02515110	Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer	active not recruiting	N/A	137	Virginia Commonwealth UniversityOTHER	1